The Novartis Foundation and Microsoft are partnering to develop an Artificial Intelligence (AI)-enabled Digital Health tool and a Leprosy Intelligent Image Atlas to aid in the early detection of leprosy
BASEL, Switzerland, March 26, 2018 /3BL Media/ – The Novartis Foundation and Microsoft are partnering to develop an Artificial Intelligence (AI)-enabled Digital Health tool and a Leprosy Intelligent Image Atlas to aid in the early detection of leprosy. Over 200,000 people are diagnosed with leprosy every year. Brazil, India, and Indonesia account for about 80% of new cases. If untreated, patients are left with lifelong disabilities and are often stigmatized in their societies.
WASHINGTON, D.C., January 19, 2018 /3BL Media/ - What do cervical cancer, Type 2 diabetes, and hypertension have in common? They are three diseases that are largely preventable, easily screened for/diagnosed, and highly treatable with known therapies. Addressing non-communicable diseases (NCDs) such as these, is a problem we can solve if we work together.
On World Heart Day 2017, the Novartis Foundation and our partners are proud to report the ambitious steps we are taking around the world to tackle hypertension in low- and middle-income countries (LMICs).
Cardiovascular diseases, including hypertension, account for nearly half of the world’s deaths from non-communicable diseases (NCDs). With almost 75% of NCD deaths occurring in LMICs, the Novartis Foundation recognizes the importance of World Heart Day in raising awareness of cardiovascular disease and promoting good heart health globally.
In two articles in the Lancet Infectious Diseases, the Novartis Foundation and its partners review the historic and future innovations and game-changing strategies in leprosy elimination, calling for a global effort to make leprosy history.
July 10, 2017 /3BL Media/ - On July 7th, 2017 the Novartis Foundation and its partners published two articles that call for a global effort to make leprosy history. The reviews have been published in the Lancet Infectious Diseases, a leading journal in infectious diseases.[i]
Today in Rio de Janeiro, Brazil, researchers, policy makers and public partners with a shared interest in determining strategies to detect leprosy and stop its global transmission come together
May 30, 2017 /3BL Media/ - On May 30, 2017 together with the Oswaldo Cruz Foundation (Fiocruz), a premier research institution in Brazil focused on public health, the Novartis Foundation is co-hosting an expert meeting entitled ‘Strategies to detect and interrupt the global transmission of leprosy’ in Rio de Janeiro, Brazil.
Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
By Dr. Ann Aerts, Head of the Novartis Foundation
Walking through the wealthier streets of cities like Geneva, London or New York, it seems that health and fitness is an international obsession. National food chains boast of fresh ingredients, light options, and low-fat meals. Shelves are stacked with the trendiest superfoods – quinoa, chia seeds, kale and avocado.
Better Hearts Better Cities is an initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension
Better Hearts Better Cities is a Novartis Foundation initiative to improve cardiovascular health in low-income urban communities by addressing the prevention, management and control of hypertension.
Non-communicable diseases (NCDs), including cardiovascular disease, are a growing health crisis with 75% of NCD deaths occurring in low- and middle-income countries; this is compounded by rapid urbanization.
The innovative approach is being tested on three continents: in Mongolia, Senegal, and Brazil.
Despite its promise, digital health is yet to reach scale in many of the countries which need it most. A new report from the Novartis Foundation, Nokia and the Broadband Commission Working Group on Digital Health explores what it takes to change this.
The potential for harnessing the exponential growth in information and communications technology (ICT) to meet health challenges is clear. Mobile is the fastest adopted technology of all time: in 1991, mobile cellular penetration stood at less than 1%, compared to 99.7% in 2016 – and there will be an estimated 5.6 billion smartphones by 2020. Around 90% of that growth will come from low- and middle-income countries (LMICs).
More than half the world’s population now lives in urban areas and healthcare services in growing cities are struggling. Experts from around the world are in Cape Town this week to discuss this growing health challenge.
Rapid urbanization in low- and middle-income countries is having a significant impact on the health and wellbeing on the world’s population. For the first time in history, more than 50% of the world’s population lives in an urban area – and by 2050, it’s estimated that 70% of will be living in towns and cities. Healthcare services in growing cities are struggling, and are already swamped with ongoing challenges like infectious diseases.
The Novartis Foundation shares four new Global Health Stories to highlight the impact of leprosy on patients, families and communities and our work to stop it.
As part of the Novartis Foundation’s effort to document the impact of leprosy on patients, their families and communities – as well as our work to stop it – we have added four new entries to our visual story-telling platform, called Global Health Stories.